These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 31005226)

  • 21. Modeling daily changes in organ-at-risk anatomy in a cohort of pancreatic cancer patients.
    Magallon-Baro A; Loi M; Milder MTW; Granton PV; Zolnay AG; Nuyttens JJ; Hoogeman MS
    Radiother Oncol; 2019 May; 134():127-134. PubMed ID: 31005206
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In Silico Trial of MR-Guided Midtreatment Adaptive Planning for Hypofractionated Stereotactic Radiation Therapy in Centrally Located Thoracic Tumors.
    Henke LE; Kashani R; Hilliard J; DeWees TA; Curcuru A; Przybysz D; Green O; Robinson CG; Bradley JD
    Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):987-995. PubMed ID: 29953910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of online adaptive MR-guided stereotactic body radiotherapy of liver cancers.
    Padgett KR; Simpson G; Asher D; Portelance L; Bossart E; Dogan N
    Phys Med; 2020 Sep; 77():54-63. PubMed ID: 32781388
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Benefit of replanning in MR-guided online adaptive radiation therapy in the treatment of liver metastasis.
    Mayinger M; Ludwig R; Christ SM; Dal Bello R; Ryu A; Weitkamp N; Pavic M; Garcia Schüler H; Wilke L; Guckenberger M; Unkelbach J; Tanadini-Lang S; Andratschke N
    Radiat Oncol; 2021 May; 16(1):84. PubMed ID: 33947429
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interfractional dose variations in the stomach and the bowels during breathhold intensity-modulated radiotherapy for pancreatic cancer: Implications for a dose-escalation strategy.
    Nakamura A; Shibuya K; Nakamura M; Matsuo Y; Shiinoki T; Nakata M; Mizowaki T; Hiraoka M
    Med Phys; 2013 Feb; 40(2):021701. PubMed ID: 23387724
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dosimetric impact of different CT datasets for stereotactic treatment planning using 3D conformal radiotherapy or volumetric modulated arc therapy.
    Oechsner M; Odersky L; Berndt J; Combs SE; Wilkens JJ; Duma MN
    Radiat Oncol; 2015 Dec; 10():249. PubMed ID: 26626865
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fast and robust online adaptive planning in stereotactic MR-guided adaptive radiation therapy (SMART) for pancreatic cancer.
    Bohoudi O; Bruynzeel AME; Senan S; Cuijpers JP; Slotman BJ; Lagerwaard FJ; Palacios MA
    Radiother Oncol; 2017 Dec; 125(3):439-444. PubMed ID: 28811038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Feasibility of helical tomotherapy in stereotactic body radiation therapy for centrally located early stage non‒small-cell lung cancer or lung metastases.
    Chi A; Jang SY; Welsh JS; Nguyen NP; Ong E; Gobar L; Komaki R
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):856-62. PubMed ID: 21255942
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elective nodal irradiation with simultaneous integrated boost stereotactic body radiotherapy for pancreatic cancer: Analyses of planning feasibility and geometrically driven DVH prediction model.
    Nakamura A; Prichard HA; Wo JY; Wolfgang JA; Hong TS
    J Appl Clin Med Phys; 2019 Feb; 20(2):71-83. PubMed ID: 30636367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Calculating the individualized fraction regime in stereotactic body radiotherapy for non-small cell lung cancer based on uncomplicated tumor control probability function.
    Lu JY; Lin PX; Huang BT
    Radiat Oncol; 2019 Jun; 14(1):111. PubMed ID: 31221159
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of Daily Plan Adaptation in MR-Guided Stereotactic Ablative Radiation Therapy for Adrenal Metastases.
    Palacios MA; Bohoudi O; Bruynzeel AME; van Sörsen de Koste JR; Cobussen P; Slotman BJ; Lagerwaard FJ; Senan S
    Int J Radiat Oncol Biol Phys; 2018 Oct; 102(2):426-433. PubMed ID: 29902559
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simulated daily plan adaptation for magnetic resonance-guided liver stereotactic body radiotherapy.
    Taylor E; Lukovic J; Velec M; Shessel A; Stanescu T; Dawson L; Létourneau D; Lindsay P
    Acta Oncol; 2021 Feb; 60(2):260-266. PubMed ID: 33170058
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potential dosimetric benefits of adaptive tumor tracking over the internal target volume concept for stereotactic body radiation therapy of pancreatic cancer.
    Karava K; Ehrbar S; Riesterer O; Roesch J; Glatz S; Klöck S; Guckenberger M; Tanadini-Lang S
    Radiat Oncol; 2017 Nov; 12(1):175. PubMed ID: 29121945
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Volumetric modulated arc therapy treatment planning of thoracic vertebral metastases using stereotactic body radiotherapy.
    Mallory M; Pokhrel D; Badkul R; Jiang H; Lominska C; Wang F
    J Appl Clin Med Phys; 2018 Mar; 19(2):54-61. PubMed ID: 29349867
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potential reduction of lung dose via VMAT with jaw tracking in the treatment of single-isocenter/two-lesion lung SBRT.
    Pokhrel D; Sanford L; Halfman M; Molloy J
    J Appl Clin Med Phys; 2019 May; 20(5):55-63. PubMed ID: 30955251
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stereotactic body radiation therapy for liver tumors: impact of daily setup corrections and day-to-day anatomic variations on dose in target and organs at risk.
    Méndez Romero A; Zinkstok RT; Wunderink W; van Os RM; Joosten H; Seppenwoolde Y; Nowak PJ; Brandwijk RP; Verhoef C; IJzermans JN; Levendag PC; Heijmen BJ
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1201-8. PubMed ID: 19386435
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dosimetric impact of intrafraction motion under abdominal compression during MR-guided SBRT for (Peri-) pancreatic tumors.
    Grimbergen G; Eijkelenkamp H; Heerkens HD; Raaymakers BW; Intven MPW; Meijer GJ
    Phys Med Biol; 2022 Sep; 67(18):. PubMed ID: 36041431
    [No Abstract]   [Full Text] [Related]  

  • 38. Stereotactic body radiotherapy (SBRT) in recurrent or oligometastatic pancreatic cancer : A toxicity review of simultaneous integrated protection (SIP) versus conventional SBRT.
    Gkika E; Adebahr S; Kirste S; Schimek-Jasch T; Wiehle R; Claus R; Wittel U; Nestle U; Baltas D; Grosu AL; Brunner TB
    Strahlenther Onkol; 2017 Jun; 193(6):433-443. PubMed ID: 28138949
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dosimetric impact of interfraction prostate and seminal vesicle volume changes and rotation: A post-hoc analysis of a phase III randomized trial of MRI-guided versus CT-guided stereotactic body radiotherapy.
    Ma TM; Neylon J; Casado M; Sharma S; Sheng K; Low D; Yang Y; Steinberg ML; Lamb J; Cao M; Kishan AU
    Radiother Oncol; 2022 Feb; 167():203-210. PubMed ID: 34979212
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dosimetric Evaluation of Incorporating Patient Geometric Variations Into Adaptive Plan Optimization Through Probabilistic Treatment Planning in Head and Neck Cancers.
    Liu Q; Liang J; Zhou D; Krauss DJ; Chen PY; Yan D
    Int J Radiat Oncol Biol Phys; 2018 Jul; 101(4):985-997. PubMed ID: 29976511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.